Atrial natriuretic peptide preserves endothelial function during intimal hyperplasia

Journal of Vascular Research

Volumn 42, Issue 2, 2005, Pages 101-110

  Barber, Melissa N ^a,b   Gaspari, Tracey A ^b   Kairuz, Evette M ^a   Dusting, Gregory J ^a   Woods, Robyn L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Atherosclerosis; Carotid arteries; Endothelial function; Intimal hyperplasia; Natriuretic peptides; Restenosis

Indexed keywords

ACETYLCHOLINE; ATRIAL NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE C; SODIUM CHLORIDE; VASODILATOR AGENT;

ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CELL MIGRATION; CELL PROLIFERATION; COMMON CAROTID ARTERY; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM; HYPERPLASIA; INTIMA; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RESTENOSIS; VASCULAR SMOOTH MUSCLE; VASODILATATION; ANIMAL; DRUG DELIVERY SYSTEM; DRUG EFFECT; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ANIMALS; ATRIAL NATRIURETIC FACTOR; CAROTID ARTERY, COMMON; DRUG DELIVERY SYSTEMS; ENDOTHELIUM, VASCULAR; HYPERPLASIA; MALE; NATRIURETIC PEPTIDE, C-TYPE; RABBITS; TUNICA INTIMA; VASODILATION; VASODILATOR AGENTS;

EID: 18044376805     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083429     Document Type: Article

References (29)

1. Ross R, Glomset JA: Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 1973;180:1332-1339.
2. Schwartz RS: Pathophysiology of restenosis: Interaction of thrombosis, hyperplasia, and/or remodeling. Am J Cardiol 1998;81:14E-17E.
3. Arthur JF, Dusting GJ, Woodman OL: Impaired vasodilator function of nitric oxide associated with developing neo-intima in conscious rabbits. J Vasc Res 1994;31:187-194.
4. De Meyer GR, Bult H, Ustunes L, Kockx MM, Feelisch M, Herman AG: Effect of nitric oxide donors on neointima formation and vascular reactivity in the collared carotid artery of rabbits. J Cardiovasc Pharmacol 1995;26:272-279.
5. Booth RF, Martin JF, Honey AC, Hassall DG, Beesley JE, Moncada S: Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. Atherosclerosis 1989;76:257-268.
6. Dusting GJ, Curcio A, Harris PJ, Lima B, Zambetis M, Martin JF: Supersensitivity to vasoconstrictor action of serotonin precedes the development of atheroma-like lesions in the rabbit. J Cardiovasc Pharmacol 1990;16:667-674.
7. Gaspari TA, Barber MN, Woods RL, Dusting GJ: Type-C natriuretic peptide prevents development of experimental atherosclerosis in rabbits. Clin Exp Pharmacol Physiol 2000;27:653-655.
8. Kockx MM, De Meyer GR, Andries LJ, Bult H, Jacob WA, Herman AG: The endothelium during cuff-induced neointima formation in the rabbit carotid artery. Arterioscler Thromb 1993;13:1874-1884.
9. Shinomiya M, Tashiro J, Saito Y, Yoshida S, Furuya M, Oka N, Tanaka S, Kangawa K, Matsuo H: C-type natriuretic peptide inhibits intimal thickening of rabbit carotid artery after balloon catheter injury. Biochem Biophys Res Commun 1994;205:1051-1056.
10. Ueno H, Haruno A, Morisaki N, Furuya M, Kangawa K, Takeshita A, Saito Y: Local expression of C-type natriuretic peptide markedly suppresses neointimal formation in rat injured arteries through an autocrine/paracrine loop. Circulation 1997;96:2272-2279.
11. Doi K, Ikeda T, Itoh H, Ueyama K, Hosoda K, Ogawa Y, Yamashita J, Chun TH, Inoue M, Masatsugu K, Sawada N, Fukunaga Y, Saito T, Sone M, Yamahara K, Kook H, Komeda M, Ueda M, Nakao K: C-type natriuretic peptide induces redifferentiation of vascular smooth muscle cells with accelerated reendothelialization. Arterioscler Thromb Vasc Biol 2001;21:930-936.
12. Abell TJ, Richards AM, Ikram H, Espiner EA, Yandle T: Atrial natriuretic factor inhibits proliferation of vascular smooth muscle cells stimulated by platelet-derived growth factor. Biochem Biophys Res Commun 1997;17:731-736.
13. Furuya M, Yoshida M, Hayashi Y, Ohnuma N, Minamino N, Kangawa K, Matsuo H: C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells. Biochem Biophys Res Commun 1991;177:927-931.
14. Ikeda M, Kohno M, Yokohawa K, Horio T, Ueda M, Morisaki N, Yoshikawa J: Natriuretic peptide family as a novel antimigration factor of vascular smooth muscle. Arterioscler Thromb Vasc Biol 1997;17:731-736.
15. Edwards BS, Zimmerman RS, Schwab TR, Heublein DM, Burnett JC Jr: Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res 1988;62:191-195.
16. Lang RE, Tholken H, Ganten D, Luft FC, Ruskoaho H, Unger T: Atrial natriuretic factor - a circulating hormone stimulated by volume loading. Nature 1985;314:264-266.
17. Okahara K, Kambayashi J, Ohnishi T, Fujiwara Y, Kawasaki T, Monden M: Shear stress induces expression of CNP gene in human endothelial cells. FEBS Lett 1995;373:108-110.
18. Suga S, Itoh H, Komatsu Y, Ogawa Y, Hama N, Yoshimasa T, Nakao K: Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells - evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells. Endocrinology 1993;133:3038-3041.
19. Waldman SA, Rapoport RM, Murad F: Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues. J Biol Chem 1984;259:14332-14334.
20. Chinkers M, Garbers DL, Chang MS, Lowe DG, Chin HM, Goeddel DV, Schulz S: A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 1989;338:78-83.
21. Koller KJ, Lowe DG, Bennett GL, Minamino N, Kangawa K, Matsuo H, Goeddel DV: Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 1991;252:120-123.
22. Suga S, Nakao K, Hosoda K, Mukoyama M, Ogawa Y, Shirakami G, Arai H, Saito Y, Kambayashi Y, Inouye K: Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 1992;130:229-239.
23. Paravicini TM, Gulluyan LM, Dusting GJ, Drummond GR: Increased NADPH oxidase activity, gp91phox expression, and endothelium-dependent vasorelaxation during neointima formation in rabbits. Circ Res 2002;91:54-61.
24. Ross R, Glomset JA: The pathogenesis of atherosclerosis. N Engl J Med 1976;295:369-377, 420-425.
25. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-126.
26. Chang MS, Lowe DG, Lewis M, Hellmiss R, Chen E, Goeddel DV: Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature 1989;341:68-72.
27. Brown J, Chen Q: Regional expression of natriuretic peptide receptors during the formation of arterial neointima in the rabbit. Circ Res 1995;77:906-918.
28. Kockx MM, De Meyer GR, Jacob WA, Bult H, Herman AG: Triphasic sequence of neointimal formation in the cuffed carotid artery of the rabbit. Arterioscler Thromb 1992;12:1447-1457.
29. Suga S, Nakao K, Kishimoto I, Hosoda K, Mukoyama M, Arai H, Shirakami G, Ogawa Y, Komatsu Y, Nakagawa O: Phenotype-related alteration in expression of natriuretic peptide receptors in aortic smooth muscle cells. Circ Res 1992;71:34-39.